New Sodium-Glucose Transporter 2 Inhibitors Study Findings Recently Were Reported by a Researcher at Charite - University Medicine Berlin (Reno-protective Effects of Empagliflozin are linked to Activation of the Tubuloglomerular Feedback ...).

Předmět:
Zdroj: Diabetes Week; 2/27/2023, p178-178, 1p
Databáze: Complementary Index